Literature DB >> 23048210

Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats.

Isabel Rodríguez-Gómez1, Inmaculada Banegas, Rosemary Wangensteen, Andrés Quesada, Rosario Jiménez, Mercedes Gómez-Morales, Francisco O'Valle, Juan Duarte, Félix Vargas.   

Abstract

The purpose was to analyse the cardiac and renal capillary density and glomerular morphology resulting from a chronic excess or deficiency of thyroid hormones (THs) in rats. We performed histopathological, morphometrical and immunohistochemical analyses in hypothyroid and hyperthyroid rats to evaluate the density of mesenteric, renal and cardiac vessels at 4 weeks after induction of thyroid disorders. The main angiogenic factors in plasma, heart and kidney were measured as possible mediators of vascular changes. Mesenteric vessel branching was augmented and decreased in hyper- and hypothyroid rats respectively. The numerical density of CD31-positive capillaries was higher in left and right ventricles and in cortical and medullary kidney from both hyper- and hypothyroid rats vs controls. Numbers of podocytes and glomeruli per square millimetre were similar among groups. Glomerular area and percentage mesangium were greater in the hyperthyroid vs control or hypothyroid groups. No morphological renal lesions were observed in any group. Vascularisation of the mesenteric bed is related to TH levels, but an increased capillarity was observed in heart and kidney in both thyroid disorders. This increase may be produced by higher tissue levels of angiogenic factors in hypothyroid rats, whereas haemodynamic factors would predominate in hyperthyroid rats. Our results also indicate that the renal dysfunctions of thyroid disorders are not related to cortical or medullary microvascular rarefaction and that the proteinuria of hyperthyroidism is not secondary to a podocyte deficit. Finally, TH or its analogues may be useful to increase capillarity in renal diseases associated with microvascular rarefaction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23048210     DOI: 10.1530/JOE-12-0208

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  17 in total

Review 1.  The correct renal function evaluation in patients with thyroid dysfunction.

Authors:  Mariadelina Simeoni; Annamaria Cerantonio; Ida Pastore; Rossella Liguori; Marta Greco; Daniela Foti; Elio Gulletta; Antonio Brunetti; Giorgio Fuiano
Journal:  J Endocrinol Invest       Date:  2015-10-28       Impact factor: 4.256

2.  Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes.

Authors:  Valentina Benedetti; Angelo Michele Lavecchia; Monica Locatelli; Valerio Brizi; Daniela Corna; Marta Todeschini; Rubina Novelli; Ariela Benigni; Carlamaria Zoja; Giuseppe Remuzzi; Christodoulos Xinaris
Journal:  JCI Insight       Date:  2019-09-19

Review 3.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

Review 4.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

5.  Kidney disease and thyroid dysfunction: the chicken or egg problem.

Authors:  Fabian Echterdiek; Michael B Ranke; Vedat Schwenger; Uwe Heemann; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2022-06-23       Impact factor: 3.651

Review 6.  Intravoxel Incoherent Motion Magnetic Resonance Imaging in Skeletal Muscle: Review and Future Directions.

Authors:  Erin K Englund; David A Reiter; Bahar Shahidi; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2021-08-14       Impact factor: 5.119

Review 7.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

Review 8.  The interaction between thyroid and kidney disease: an overview of the evidence.

Authors:  Connie M Rhee
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

9.  L-Arginine metabolism in cardiovascular and renal tissue from hyper- and hypothyroid rats.

Authors:  Isabel Rodríguez-Gómez; Juan N Moliz; Andrés Quesada; Sebastian Montoro-Molina; Pablo Vargas-Tendero; Antonio Osuna; Rosemary Wangensteen; Félix Vargas
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-15

Review 10.  The Interplay Between Thyroid Dysfunction and Kidney Disease.

Authors:  Yoko Narasaki; Peter Sohn; Connie M Rhee
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.